IDEAS home Printed from https://ideas.repec.org/a/sae/clnure/v31y2022i6p1080-1090.html
   My bibliography  Save this article

Severity, Risk Factors and Quality of Life of Patients associated with Chemotherapy-Induced Peripheral Neuropathy

Author

Listed:
  • Saumya P. Srivastava
  • Aditi Prashant Sinha
  • Kamlesh Kumari Sharma
  • Prabhat Singh Malik

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) refers to numbness, tingling, and burning sensation caused by chemotherapy that can cause impairment in Quality of Life (QoL) of the patients. Study assesses severity, risk factors, and quality of life of patients associated with CIPN. A cross sectional descriptive study was conducted at day care ward, tertiary care hospital India. Total of 98 patients receiving paclitaxel for ≥4 months were enrolled by convenient sampling. Data regarding demographics and clinical characteristics, CIPN severity, risk factors, and QoL were collected by structured questionnaires. Study revealed that median score of autonomic symptoms was higher than sensory and motor symptoms. Mean score of FACT/GOG-Ntx sub-domain was 99.05 ± 20.87on a scale of 0 to 152. ECOG Performance status, current exercise behavior, and fruit and vegetable intake was found to be significantly (at p  

Suggested Citation

  • Saumya P. Srivastava & Aditi Prashant Sinha & Kamlesh Kumari Sharma & Prabhat Singh Malik, 2022. "Severity, Risk Factors and Quality of Life of Patients associated with Chemotherapy-Induced Peripheral Neuropathy," Clinical Nursing Research, , vol. 31(6), pages 1080-1090, July.
    • Handle: RePEc:sae:clnure:v:31:y:2022:i:6:p:1080-1090
    DOI: 10.1177/10547738221085613
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/10547738221085613
    Download Restriction: no
    File URL: https://libkey.io/10.1177/10547738221085613?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:clnure:v:31:y:2022:i:6:p:1080-1090. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.